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Summary.-The development of cellular immunity to a syngeneic squamous cell
carcinoma in Wistar rats was studied by in vitro microcytotoxicity assay. Reactivity
of lymphocytes from lymph nodes, spleen and blood was tested throughout the period
of tumour growth. Maximum lymphocyte cytotoxicity against the tumour was
observed at 2 weeks in regional lymph nodes, 4 weeks in intermediate nodes, spleen
and blood, and 6 weeks in distant nodes; the intensity of these cytotoxic responses
subsequently declined. In the regional nodes, lymphocytes became totally unres-
ponsive despite the maintenance of significant cytotoxicity in intermediate nodes,
spleen and blood. Local anergy may account for tumour spread to the regional node
in an otherwise immunocompetent host. This anergy may be due to high local
concentration of tumour antigen or antigen-antibody complexes, but it was not
associated with selective changes in T and B cell proportions.
IMMUNOLOGICAL reactivity against
autologous tumour has been demonstrated
in human subjects (reviewed by Oettgen,
Old and Boyse, 1971) and in experimental
animals (reviewed by Hellstrom and
Hellstrom, 1971). One explanation of the
inability of this response to prevent
tumour metastasis to regional lymph
nodes is a local immune deficiency.
Clinical studies have revealed cases with
positive blood lymphocyte cytotoxicity
against the patient's tumour cells, but no
reactivitv by regional lymph node lympho-
cytes (DiSaia et al., 1971 ; Nairn et al.,
1971, 1972; Vanky and Stjernsward,
1971; Nairn, 1973; Nind et al., 1973).
Others have also shown that progressive
loss of lymph node lymphocyte reactivity
precedes that of spleen and blood in
tumour bearing animals (Bellone and
Pollard, 1970; Firket and Lafontaine,
1972; Landazuri and Herberman, 1972).
We have observed a similar loss of
lymphocyte reactivity in rats bearing a
syngeneic squamous cell carcinoma during
a study of the development of cellular
immunity in various lymphoid tissues.
In an attempt to elucidate the nature of
the phenomenon, T and B cell proportions
in the lymphoid tissueshave beent assessed.
The possible role of serum factors has
also been investigated and is reported in
afollowing communication (Flannery et al.,
1973).
MATERIALS AND METHODS
Animals and tumour
Inbred Wistar rats obtained from Pro-
fessor R. W. Baldwin, Nottingham, and
maintained at Monash University, were used
at 3-4 months in all studies. A spontaneous
squamous cell carcinoma which had arisen in
a female rat of the strain (Baldwin, 1966)
was maintained by serial passage sub-
cutaneously of tumour fragments or cell
suspensions prepared by mincing excised
tumour with scalpel blades in medium 199
containing 20% foetal calf serum. Viability
was assessed by exclusion of trypan blue dye
at a concentration of 0.1o%. Tumour cell
suspensions used for inoculation and for
cytotoxicity assays were taken from a
common stock of frozen cells preserved w%ithIMMUNE RESPONSE TO A SYNGENEIC RAT TUMOUR
100/0 dimethylsulphoxide in liquid nitrogen.
Previous experiments have shown fresh and
frozen tumour cells to be equally effective as
antigenic targets in the microcytotoxicity
assay.
Tumour growth in vivo
Rats were inoculated subcutaneously in
the medial aspect of the right thigh with 103
viable tumour cells, previously shown to
produce tumours in all animals and death in
8-10 weeks. Groups of 4 animals were killed
2, 4, 6 and 8 weeks after tumour inoculation,
the volumes of the primary tumours deter-
mined and tissues from various organs taken
for histological evidence of dissemination.
Tumour volumes were calculated from mean
diameters assuming the tumours to be
spherical.
Immunological studies in vitro
Lymphocytes.-Each animal was bled out
and right inguinal node (regional node),
para-aortic nodes (intermediate nodes), cer-
vical nodes (distant nodes) and spleens were
removed. Cell suspensions were prepared
by gentle teasing with 21-gauge needles in
medium 199 containing 20% foetal calf
serum. Lymphocytes from spleen and
heparinized blood were separated from other
cell types by a combination of 2 procedures.
Phagocytic cells (granulocytes and macro-
phages) wiere removed by adherence to a
glass-wool column and erythrocytes were
separated on a discontinuous density gradient
of Ficoll-Hypaque (Yamana, Rolland and
Nairn, 1973).
Cytotoxicity tests were carried out in
Falcon microtitration plates (No. 3034,
Falcon Plastics Co.) using a modification of
the procedures of Takasugi and Klein (1970).
Tumour cell suspension (10 ,ul) containing 2-5
or 5.0 x 104 cells/ml in medium 199 was
placed in each well and allowed to stand at
37°C overnight. The number of cells ad-
herent to the base of each well after washing
was then counted by phase contrast micro-
scopy. Wells containing 100-150 cells were
used in all tests. Lymphocyte suspension
(10 ,ul) containing 1-25-2-5 x 106 viable
cells/ml was then added to each well, giving
a final lymphocyte to tumour ratio of250: 1.
Control lymphocytes were obtained from
the corresponding sources in normal, healthy
animals. At least 4 replicates of each test
9
well were used. After 4 hours at 37°C, the
plates were gently washed twice with warm
medium to remove non-adhering lymphocytes
and incubated for a further 40-48 hours at
37°C. The plates were then washed twice,
fixed and stained with Leishman's stain and
the number of tumour cells adhering to each
well bottom was counted bylight microscopy.
Cytotoxicity was expressed as the percentage
reduction in the mean number of surviving
tumour cells in test (Nt) versus control (Nc)
wells, i.e.
__Nc -Nt cytotoxicity=- Nc - x 100.
Student's t-tests were performed to esti-
mate the statistical significance of differences
between cytotoxicity means and a difference
was considered significant at the P < 0-05
level.
T and B lymphocytes.-The relative
proportions ofT and B cells in the suspensions
were determined by membrane immuno-
fluorescenceusingfluorescein-conjugated anti-
rat globulin (Yamana et al., 1973). This
conjugate had activity against IgG and IgM
and a fluorescein to protein molar ratio of
4-3 :1. It was absorbed with human liver
powder, bovine liver homogenate and washed
rat erythrocytes and when used at a globulin
concentration of 0 7 g/lOOml gave no sig-
nificant staining of thymocytes (T cells) but
bright membrane staining of a proportion of
lymphocytes (B cells) from other lymphoid
tissues. A total of 100-200 lymphocytes was
counted in each preparation to obtain the
percentage of stained cells. Normal values
were similarly determined for equivalent
tissues from 10 normal, healthy animals.
RESULTS
Tumour growth
Tumours became palpable 2-4 weeks
after inoculation (Fig. 1) and then in-
creased rapidly in volume reaching a mean
size of 17-1 + 8.0 cm3 at Week 8. Meta-
stases were observed microscopically in
the lungs of some animals at Week 4 and
of all animals by Week 6.
Splenomegaly was evident in animals
with advanced tumour. Mean spleen
weights of tumour bearing animals at
Weeks 2 and 8 were 479 ± 43 mg and
728 +98 mg respectively.
119120 G. R. FLANNERY, P. J. CHALMERS, J. M. ROLLAND AND R. C. NAIRN
0 2 4 6 8
Duration of tumour growth (weeks)
100.0,
E
0
10.0 E g 0
I-
1.0 0
E
1a) 0.1 E
FIG. 1 -Tumour growth curve and evolution of cellular cytotoxicity in lymph nodes. Each point
represents the mean of 4 animals. Intermediate node cytotoxicity significantly greater than
regional node at Week 6 (P < 0 05) and Week 8 (P < 0-01).
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FIG. 2.-Evolution of cellular cytotoxicity in regional node, spleen and blood during tumour growth.
Each point represents the mean of 4 animals. Spleen and blood cytotoxicity significantly greater
than regional node at Weeks 6 and 8. P < 0-001 (spleen), P < 0-01 (blood).
Lymphocytotoxicity
The time course of cytotoxic reactivity
is shown in Fig. 1 and 2, in which mean
values are plotted. Cytotoxicity was
first detected in regional nodes at Week 2
and in intermediate nodes, spleen and
blood at Week 4. After an initial rise,
reactivity in regional nodes and blood
declined, becoming negligible in regional
nodesby Week 6though intermediate node
and spleen reactivities were maintained.
Distant nodes showed only a transient
response at Week 6. Reactivity of crude
spleen suspensions was also assessed but
was not found to differ significantly from
purified splenic lymphocyte preparations.
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TABLE I. B Cell Percentages in Various Lymphoid Tissues During
Tumour Growth, Mean Values and Standard Error
Lymphocytes
Week
4
6
8
Normal controls
Lymph nodes
Regional Intermediate Distant
19±2-4 22±3-3 30±15
14±2 .5 15±1*3 19±2-1
17±1 2 19±1 *2 24±2-0
20±19 9 21±2-1 22±1 *2
20--0 9
T and B lymphocytes
Relative proportions of T and B cells
in the various lymphoid tissues studied
are shown in Table I; mean B cell per-
centages are given. At no time did the
results differ significantly from normal
values. The apparent rise in blood
lymphocyte B cell count at Week 4, the
time of maximum blood lymphocyte
cytotoxicity, was not found to be statistic-
ally significant.
DISCUSSION
We have observed the development
of local lymphocyte anergy in animals
with progressively growing tumour.
Regional node lymphocytes were at first
reactive but later showed no cytotoxicity
against the tumour despite persistent
anti-tumour reactivity by other lymphoid
tissues. The mechanism responsible for
the development of this anergy is unclear
but the results of the present study show
a relationship with the time and extent of
tumour growth. Its onset follows the
exponential phase of tumour growth,
coinciding withthe detection ofmetastases.
Loss of reactivity was not correlated
with selective changes in lymphocvte
populations as shown by T and B cell
proportions. Loring and Schlesinger
(1970) have also failed to demonstrate
changes in T cell proportions in the lymph
nodes of tumour bearing mice, but
morphological studies have shown changes
in the proportions of immunoblasts
and plasma cells in the regional node
(Alexander et al., 1969; Edwards et al.,
1971).
The observed decline in immuno-
reactivity of other lymphoid tissues late
in tumour growth does not appear to
reflect general immunological debilitation
as normal responses to sheep erythrocytes
and killed Brucella abortus organisms
have been demonstrated in these animals
(Flannery et al., 1973). The response of
regional node lymphocytes to phyto-
haemagglutinin (PHA) was investigated
in order to determine whether the anergic
state was the result of a general impair-
ment of T cell function. Our results have
so far been inconclusive but clinical
studies have demonstrated normal
(Benezra and Hockman, 1971) and even
increased (Fisher, Saffer and Fisher, 1972)
response to PHA by regional node lympho-
cvtes of cancer patients.
The source of effector cells responsible
for continued activity of spleen' and blood
lymphocytes is of some interest. Spleno-
megaly observed in the present study and
by others (e.g. Blamey and Ev'ans, 1971)
suggests the spleen as a possible source
(see also Nind et al., 1973).
Serum factors may be responsible for
the development of local lymphocyte
anergy, acting on tumour (Hellstrom
et al., 1971; Sjogren et al., 1972) or on
lymphocytes (Currie and Basham, 1972;
Field and Caspary, 1972). Such factors
must include some local component,
presumably tumour antigen (Alexander,
1970) or antigen-antibody complexes
(Baldwin, Price and Robins, 1972; Sjogren
Spleen
32±1 5 5
24±2 *5
17±1 *5
20i- 0 6
29'3 34
Blood
18±1 5
2(±2 - 8
11±1*4
13±1.5
16@ 1 * 7
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et al., 1972) to account for the early local
occurrence of anergy. Blocking activity
is currently being investigated and sera
from rats of our study, bearing advanced
tumours, have been shown to inhibit the
lymphocytotoxicity reaction (Flannery et
al., 1973).
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